These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 27659401

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Markers of Iron Status Are Associated with Risk of Hyperuricemia among Chinese Adults: Nationwide Population-Based Study.
    Li X, He T, Yu K, Lu Q, Alkasir R, Guo G, Xue Y.
    Nutrients; 2018 Feb 09; 10(2):. PubMed ID: 29425155
    [Abstract] [Full Text] [Related]

  • 24. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L, Swinkels DW, Burdick L, Dongiovanni P, Tjalsma H, Motta BM, Bertelli C, Fatta E, Bignamini D, Rametta R, Fargion S, Fracanzani AL.
    Nutr Metab Cardiovasc Dis; 2011 Aug 09; 21(8):568-75. PubMed ID: 20392616
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Natural history of the C282Y homozygote for the hemochromatosis gene (HFE) with a normal serum ferritin level.
    Yamashita C, Adams PC.
    Clin Gastroenterol Hepatol; 2003 Sep 09; 1(5):388-91. PubMed ID: 15017658
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
    Wrede CE, Hutzler S, Bollheimer LC, Buettner R, Hellerbrand C, Schöelmerich J, Palitzsch KD.
    Isr Med Assoc J; 2004 Jan 09; 6(1):30-3. PubMed ID: 14740507
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression.
    Distante S, Berg JP, Lande K, Haug E, Bell H.
    Scand J Gastroenterol; 1999 May 09; 34(5):529-34. PubMed ID: 10423072
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The evaluation of hyperferritinemia: an updated strategy based on advances in detecting genetic abnormalities.
    Aguilar-Martinez P, Schved JF, Brissot P.
    Am J Gastroenterol; 2005 May 09; 100(5):1185-94. PubMed ID: 15842597
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Quality of Life Scores Remained Different among the Genotypic Groups of Patients with Suspected Hemochromatosis, Even after Treatment Period.
    Acevedo LAU, Alvarenga AM, Fonseca PFS, da Silva NK, Cançado RD, Naoum FA, Dinardo CL, Pereira AC, Brissot P, Santos PCJL.
    Genes (Basel); 2022 Jan 10; 13(1):. PubMed ID: 35052458
    [Abstract] [Full Text] [Related]

  • 40. [Management of hyperferritinemia].
    Delwaide J, Giet D, Lamproye A, Belaïche J.
    Rev Med Liege; 2006 Jan 10; 61(5-6):329-33. PubMed ID: 16910257
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.